About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline
LOG IN
LOG IN

GAO-20-584SP 1 (2020-05-20)

handle is hein.gao/gaobaebdh0001 and id is 1 raw text is: Science, Technology Assessment, G A O Iand Analytics SCIENCE & TECH SPOTLIGHT: COVID-19 TESTING What is it? There are currently three types of tests for COVID-19: molecular, antigen, and serology. Molecular tests and a new antigen test help diagnose active COVID-19 infections, and serology tests help determine whether someone was previously exposed to the novel coronavirus, which causes COVID-19. How does it work? While each kind of test takes a different approach, they all collect vital information about exposure to the virus. Molecular tests amplify and detect genetic material from novel coronavirus in a sample taken from a patient's saliva, nose, or throat to determine whether there is an active infection (fig. 1). For example, molecular tests based on the polymerase chain reaction (PCR) use a genetic photocopier, copying a unique portion of the coronavirus genetic material, if present, until there are enough copies to detect. Antigen tests can detect the virus by binding parts of the virus, called antigens, to a membrane. Antibodies that can fluoresce are also added to the membrane. If enough antigen is present to bind to the antibodies, the total fluorescence from the antibodies becomes high enough to indicate a positive result. Serology tests, which typically require a sample of blood from a patient, can detect the presence of antibodies produced by a patient's immune system in response to the coronavirus (fig. 1). Such antibodies can persist in the blood after a patient recovers from an infection. Thus, a positive serology test result indicates prior exposure to the novel coronavirus but does not necessarily mean that the patient is still infected. Molecular Virus Serology virus Amplify Viral genetic material Source: GAO. I GAO-20-584 Detect Antibodies 4SP Detect Most Common COVID-19 Test Types. Molecular tests detect viral genetic material. Serology tests detect antibodies against the virus. How mature is it? All three kinds of COVID-19 tests are commercially available under the Food and Drug Administration's (FDA's) emergency use authorization (EUA), which allows for the use of certain unapproved medical products or unapproved uses of approved medical products under certain circumstances during a public health emergency. As of May 13, 2020, FDA has authorized at least 56 molecular tests for COVID-19 via EUA; these tests generally rely on PCR technology. Devices used for administering molecular tests range in size from larger equipment to smaller, portable devices that can be used on-site near the patient. On May 8, 2020, FDA authorized the first antigen test for COVI D-1 9 via EUA. According to FDA, antigen tests, which can be run in minutes, have a higher chance of false negatives compared to molecular tests. FDA states that negative antigen test results may need to be confirmed with a molecular test before making treatment decisions. As of May 13, 2020, FDA has authorized at least 12 serology tests for COVID-19 via EUA. For COVID-19, serology tests were first authorized by FDA about a month after molecular tests were authorized. Devices used to administer serology tests also range in size, with some about the size of an over-the-counter pregnancy test. Testing provides critical information for a variety of purposes, including medical care, policymaking, and business. For example: Determining risk. Serology tests can help establish the percentage of the population previously exposed to the virus. Such information can help improve the accuracy of statistics on infection rates, among other things. Understanding disease impact. Testing can help establish the impact of the disease, including identifying those who may have been exposed to the virus but did not show symptoms and those who recovered. This is important for characterizing the risk of the disease to the elderly and other subpopulations. Guiding treatment and resource allocation. Molecular and antigen tests can provide information on the rate and geographic location of active infections. This can help guide patient treatment and inform decisions about the distribution of medical supplies and equipment. Informing responses. Testing is also important for informing decisions on quarantine and isolation, including decisions related to health care workers. Additionally, testing can help inform public responses such as school closures and reopenings. GAO-20-584SP COVID-19 Testing I

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Contact us for annual subscription options:

Contact Us

Already a HeinOnline Subscriber?

Log In

profiles profiles most